Abstract

Randomized controlled clinical trial (RCT) is considered the gold standard for efficacy evaluation of medical treatments, as well as for many other types of empirical research [1,2]. The core characteristic of RCT is the random treatment assignment, which 1) protects the integrity of trial results against selection bias and 2) provides the foundation for statistical analyses of trial data. Unrestricted randomization is rarely used in practice. Various restricted randomization designs have been proposed in the literature to control the imbalances in the sizes of and the baseline covariate distributions among the treatment groups, motivated by an effort to ensure the comparability of the treatment groups.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.